DocGo Inc. (DCGO)
$
1.42
+0.06 (4.23%)
Key metrics
Financial statements
Free cash flow per share
0.8302
Market cap
134.8 Million
Price to sales ratio
0.2589
Debt to equity
0.1967
Current ratio
2.4405
Income quality
-10.8906
Average inventory
0
ROE
-0.0020
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company recorded an operating income of $28,688,726.00 reflecting its earnings from core operations. The gross profit stands at $197,689,677.00 highlighting the company's profitability from core operations. Furthermore, the gross profit ratio is 0.32 which reflects the efficiency of the company's production and sales operations. The net income ratio is 0.03 signifying the company's profitability margin. Additionally, the company incurred an income tax expense of $14,388,422.00 indicating its tax obligations. Its transportation services include emergency response services as well as non-emergency transport options like ambulance and wheelchair transportation. Alongside these services, DocGo, Inc. offers mobile health services that are performed at home and in offices, COVID-19 testing, and event services providing on-site healthcare support at various events such as sporting matches and concerts. This dynamic range of services showcases the company's commitment to healthcare solutions. Established in 2015, DocGo, Inc. is headquartered in New York, New York. The stock is affordable at $1.36 making it suitable for budget-conscious investors. With a market capitalization of $140,728,106.00 the company is classified as a small-cap player, allowing for growth potential within its market segment. The stock has an average trading volume of 1,159,976.00 indicating moderate liquidity and facilitating easier trades for investors. It is a key player in the Medical - Care Facilities industry, contributing significantly to the overall market landscape. By belonging to the Healthcare sector, DocGo, Inc. drives innovation and growth, providing essential services that meet the evolving needs of healthcare. This strategic positioning enhances its visibility and competitiveness in the market, reflecting the company’s efforts toward expanding its influence and reach within the healthcare sector.
Investing in DocGo Inc. (DCGO) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C+, with a Bullish outlook. Always conduct your own research before investing.
Analysts predict DocGo Inc. stock to fluctuate between $1.23 (low) and $5.68 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2025-05-30, DocGo Inc.'s market cap is $140,728,106, based on 99,104,300 outstanding shares.
Compared to Meta Platforms, Inc. Class A Common Stock, DocGo Inc. has a Lower Market-Cap, indicating a difference in performance.
To buy DocGo Inc. (DCGO) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for DCGO. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Revenue: $616,555,132 | EPS: $0.20 | Growth: 201.66%.
Visit https://www.docgo.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $11.41 (2022-10-11) | All-time low: $1.23 (2025-05-22).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
prnewswire.com
NEW YORK , May 29, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of DocGo, Inc. (NASDAQ: DCGO) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, DocGo insiders caused the company to misrepresent or fail to disclose that (i) the processes DocGo used to hire executives were insufficient for thoroughly examining and verifying the professional and educational backgrounds of applicants; (ii) this inadequacy heightened the risk of disruptive changes in executive leadership; (iii) contrary to what it had communicated to investors, DocGo had overestimated the effectiveness of its mobile health and medical transportation services, which were key components of the Relocation Contract; (iv) all these issues, once disclosed, were likely to expose DocGo to considerable reputational and/or regulatory examination, adversely affecting the company's financial health and future outlook; and (v) consequently, the company's public declarations were inaccurate and misleading throughout the times in question.
businesswire.com
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, today announced that it has been selected as winner of the “Compliance Management Innovation Award” in the 9th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market. DocGo's brea.
seekingalpha.com
DocGo, Inc (NASDAQ:DCGO ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Mike Cole - VP, IR Lee Bienstock - CEO Norman Rosenberg - CFO Conference Call Participants Ryan MacDonald - Needham Kieran Ryan - Deutsche Bank Jenny Shen - BTIG Operator Good afternoon, ladies and gentlemen, and welcome to the DocGo First Quarter Earnings Conference Call. At this time, all lines are in listen-only mode.
zacks.com
DocGo Inc. (DCGO) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.09 per share a year ago.
businesswire.com
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the first quarter ended March 31st, 2025 after the markets close on Thursday, May 8th, 2025. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Thursday, May 8th, 2025 5:00 p.m. ET 1-800-717-1738 (.
prnewswire.com
NEW YORK and NEW ORLEANS , April 18, 2025 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.
businesswire.com
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced that it has been Certified™ by Great Place To Work® for the third time in a row. This prestigious award is based on what current employees say about their experience working at the Company. This year, employees rated DocGo 31% higher than the average US company as a Great Place to Work. Great Place To Work® is the global authority on w.
businesswire.com
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, today announced that Lee Bienstock, Chief Executive Officer, will participate in a fireside chat at the Needham Virtual Healthcare Conference on Monday, April 7th at 11:45 AM Eastern Time, and hold virtual 1x1 meetings as well. A webcast of the event will be available on the investor relations section of DocGo's website at https://ir.docgo.com/. About DocGo DocGo is l.
seekingalpha.com
DocGo's shares have plummeted over 45% since mid-February, declining over 20% after reporting Q4 '24 on February 27th. The company has relied on contingencies such as COVID-19 testing and large contracts for a significant part of its revenues, much of which has now dried up. The company is transitioning to a new revenue model targeting Health Insurance Partnerships, aiming for more stable and predictable revenues. Yet, this space is highly competitive.
seekingalpha.com
DocGo, Inc (NASDAQ:DCGO ) Q4 2024 Results Conference Call February 27, 2025 5:00 PM ET Company Participants Mike Cole - VP of Investor Relations Lee Bienstock - Chief Executive Officer Norman Rosenberg - Chief Financial Officer Conference Call Participants Pito Chickering - Deutsche Bank Richard Close - Canaccord Genuity David Larsen - BTIG Aidan Conniff - Stifel Operator Good afternoon, ladies and gentlemen, and welcome to the DocGo Fourth Quarter and Full Year 2024 Earnings Call. At this time, all lines are in listen only mode.
See all news